Vanhoorelbeke K - Search Results

1

Anti-cysteine/spacer antibodies that open ADAMTS13 are a common feature in iTTP.

De Waele L, Curie A, Kangro K, Tellier E, Kaplanski G, Männik A, Tersteeg C, Joly BS, Coppo P, Veyradier A, De Meyer SF, Roose E, Vanhoorelbeke K. De Waele L, et al. Among authors: vanhoorelbeke k. Blood Adv. 2021 Nov 9;5(21):4480-4484. doi: 10.1182/bloodadvances.2021004971. Blood Adv. 2021. PMID: 34559219 Free PMC article.

2

New approaches for antithrombotic antiplatelet therapies.

Ulrichts H, Vanhoorelbeke K, Van De Walle G, Katsutani S, De Meyer S, Staelens S, Deckmyn H. Ulrichts H, et al. Among authors: vanhoorelbeke k. Curr Med Chem. 2004 Sep;11(17):2261-3. doi: 10.2174/0929867043364630. Curr Med Chem. 2004. PMID: 15379711 Review.

3

False positive results in chimeraplasty for von Willebrand Disease.

De Meyer SF, Pareyn I, Baert J, Deckmyn H, Vanhoorelbeke K. De Meyer SF, et al. Among authors: vanhoorelbeke k. Thromb Res. 2007;119(1):93-104. doi: 10.1016/j.thromres.2005.12.009. Epub 2006 Feb 2. Thromb Res. 2007. PMID: 16457874

4

Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor.

De Meyer SF, Vanhoorelbeke K, Chuah MK, Pareyn I, Gillijns V, Hebbel RP, Collen D, Deckmyn H, VandenDriessche T. De Meyer SF, et al. Among authors: vanhoorelbeke k. Blood. 2006 Jun 15;107(12):4728-36. doi: 10.1182/blood-2005-09-3605. Epub 2006 Feb 14. Blood. 2006. PMID: 16478886 Free PMC article.

5

Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs.

De Meyer SF, Vanhoorelbeke K, Ulrichts H, Staelens S, Feys HB, Salles I, Fontayne A, Deckmyn H. De Meyer SF, et al. Among authors: vanhoorelbeke k. Cardiovasc Hematol Disord Drug Targets. 2006 Sep;6(3):191-207. doi: 10.2174/187152906778249536. Cardiovasc Hematol Disord Drug Targets. 2006. PMID: 17017902 Review.

6

Correction of the bleeding time in von Willebrand factor (VWF)-deficient mice using murine VWF.

Lenting PJ, de Groot PG, De Meyer SF, Vanhoorelbeke K, Pruss C, Lillicrap D, Marx I, Denis CV. Lenting PJ, et al. Among authors: vanhoorelbeke k. Blood. 2007 Mar 1;109(5):2267-8. doi: 10.1182/blood-2006-10-054718. Blood. 2007. PMID: 17312004 Free article. No abstract available.

7

The A/T1381 polymorphism in the A1-domain of von Willebrand factor influences the affinity of von Willebrand factor for platelet glycoprotein Ibalpha.

Szántó T, Schlammadinger A, Staelens S, De Meyer SF, Freson K, Pareyn I, Vauterin S, Hársfalvi J, Deckmyn H, Vanhoorelbeke K. Szántó T, et al. Among authors: vanhoorelbeke k. Thromb Haemost. 2007 Jul;98(1):178-85. Thromb Haemost. 2007. PMID: 17598011

8

Coronary artery in-stent stenosis persists despite inhibition of the von Willebrand factor--collagen interaction in baboons.

De Meyer SF, Staelens S, Badenhorst PN, Pieters H, Lamprecht S, Roodt J, Janssens S, Meiring M, Vanhoorelbeke K, Bruwer A, Brown S, Deckmyn H. De Meyer SF, et al. Among authors: vanhoorelbeke k. Thromb Haemost. 2007 Dec;98(6):1343-9. doi: 10.1160/th07-05-0335. Thromb Haemost. 2007. PMID: 18064334

9

Inherited traits affecting platelet function.

Salles II, Feys HB, Iserbyt BF, De Meyer SF, Vanhoorelbeke K, Deckmyn H. Salles II, et al. Among authors: vanhoorelbeke k. Blood Rev. 2008 May;22(3):155-72. doi: 10.1016/j.blre.2007.11.002. Epub 2008 Jan 3. Blood Rev. 2008. PMID: 18180086 Review.

10

Antiplatelet drugs.

De Meyer SF, Vanhoorelbeke K, Broos K, Salles II, Deckmyn H. De Meyer SF, et al. Among authors: vanhoorelbeke k. Br J Haematol. 2008 Aug;142(4):515-28. doi: 10.1111/j.1365-2141.2008.07233.x. Epub 2008 May 30. Br J Haematol. 2008. PMID: 18513285 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

212 results

Search Page